Eva Harris

Author PubWeight™ 171.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global spread and persistence of dengue. Annu Rev Microbiol 2008 6.44
2 Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011 5.43
3 Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 2003 4.29
4 The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006 3.69
5 The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010 3.48
6 Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 2010 3.16
7 Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 2005 3.12
8 Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol 2006 3.07
9 Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 2004 2.83
10 Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 2010 2.80
11 Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 2006 2.76
12 High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 2006 2.67
13 Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog 2010 2.62
14 Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg 2005 2.49
15 Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 2006 2.39
16 Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 2010 2.33
17 Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J Virol 2010 2.31
18 Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 2011 2.29
19 Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis 2011 2.26
20 Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol 2003 2.22
21 Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol 2010 2.14
22 The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 2009 2.14
23 Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol 2008 2.10
24 Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg 2009 1.87
25 Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology 2002 1.81
26 Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 2005 1.79
27 Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis 2007 1.71
28 High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis 2010 1.70
29 Integration of information technologies in clinical studies in Nicaragua. PLoS Med 2007 1.69
30 A novel magnetic bead bioassay platform using a microchip-based sensor for infectious disease diagnosis. J Immunol Methods 2006 1.69
31 Convergent antibody signatures in human dengue. Cell Host Microbe 2013 1.64
32 Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 2004 1.61
33 Animal models of dengue virus infection. Viruses 2012 1.60
34 Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl Trop Dis 2013 1.57
35 Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis 2009 1.55
36 Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure. Virology 2005 1.55
37 Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 2008 1.54
38 Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 2010 1.53
39 Virus identification in unknown tropical febrile illness cases using deep sequencing. PLoS Negl Trop Dis 2012 1.52
40 Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 2013 1.51
41 Quantitative assessment of the benefits of specific information technologies applied to clinical studies in developing countries. Am J Trop Med Hyg 2008 1.49
42 Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr Infect Dis J 2007 1.42
43 Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua. Clin Infect Dis 2010 1.40
44 Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl Trop Dis 2012 1.39
45 RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol 2006 1.38
46 Y box-binding protein-1 binds to the dengue virus 3'-untranslated region and mediates antiviral effects. J Biol Chem 2007 1.37
47 A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med 2014 1.37
48 Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping. J Clin Microbiol 2013 1.35
49 The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology 2008 1.31
50 Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication. J Virol 2010 1.31
51 Enhancement of dengue virus translation: role of the 3' untranslated region and the terminal 3' stem-loop domain. Virology 2004 1.30
52 Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J Clin Microbiol 2013 1.29
53 Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol 2005 1.26
54 Early clinical features of dengue virus infection in nicaraguan children: a longitudinal analysis. PLoS Negl Trop Dis 2012 1.25
55 Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J Virol 2012 1.25
56 Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners. Ann N Y Acad Sci 2007 1.25
57 Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency. J Gen Virol 2009 1.25
58 Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 2008 1.24
59 Report of an NIAID workshop on dengue animal models. Vaccine 2010 1.23
60 Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol 2011 1.22
61 The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio 2013 1.21
62 Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One 2011 1.20
63 Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. PLoS Pathog 2013 1.20
64 A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci 2009 1.20
65 End-to-end communication in the modulation of translation by mammalian RNA viruses. Virus Res 2005 1.20
66 Dengue virus modulates the unfolded protein response in a time-dependent manner. J Biol Chem 2011 1.20
67 A review of biochars' potential role in the remediation, revegetation and restoration of contaminated soils. Environ Pollut 2011 1.19
68 The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010. PLoS Negl Trop Dis 2013 1.19
69 Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited. J Virol 2006 1.17
70 Unusual dengue virus 3 epidemic in Nicaragua, 2009. PLoS Negl Trop Dis 2011 1.10
71 Oscillating kissing stem-loop interactions mediate 5' scanning-dependent translation by a viral 3'-cap-independent translation element. RNA 2006 1.10
72 Index cluster study of dengue virus infection in Nicaragua. Am J Trop Med Hyg 2010 1.08
73 Conformational changes in the solution structure of the dengue virus 5' end in the presence and absence of the 3' untranslated region. J Virol 2008 1.07
74 Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis 2010 1.05
75 Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol 2012 1.05
76 Translation efficiency determines differences in cellular infection among dengue virus type 2 strains. Virology 2003 1.04
77 Control of dengue virus translation and replication. Curr Top Microbiol Immunol 2010 1.04
78 Characterization of Aedes aegypti (Diptera: Culcidae) production sites in urban Nicaragua. J Med Entomol 2007 1.04
79 S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells. J Virol 2005 1.03
80 Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses. Emerg Infect Dis 2016 1.03
81 Severe coinfections of dengue and pandemic influenza A H1N1 viruses. Pediatr Infect Dis J 2010 1.03
82 Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis 2013 1.03
83 Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response. Am J Trop Med Hyg 2004 1.02
84 Improvement in hospital indicators after changes in dengue case management in Nicaragua. Am J Trop Med Hyg 2009 1.02
85 Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology 2012 1.01
86 From construction workers to architects: developing scientific research capacity in low-income countries. PLoS Biol 2009 0.99
87 Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children. PLoS Negl Trop Dis 2012 0.99
88 Diagnostic accuracy of a rapid influenza test for pandemic influenza A H1N1. PLoS One 2010 0.99
89 Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl Trop Dis 2013 0.98
90 The 5' and 3' downstream AUG region elements are required for mosquito-borne flavivirus RNA replication. J Virol 2010 0.98
91 Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl Trop Dis 2008 0.97
92 Clustering of Mycobacterium tuberculosis cases in Acapulco: Spoligotyping and risk factors. Clin Dev Immunol 2010 0.95
93 Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway. PLoS One 2012 0.95
94 Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions. PLoS Negl Trop Dis 2013 0.95
95 A novel coding-region RNA element modulates infectious dengue virus particle production in both mammalian and mosquito cells and regulates viral replication in Aedes aegypti mosquitoes. Virology 2012 0.94
96 Identification of Aedes albopictus in urban Nicaragua. J Am Mosq Control Assoc 2005 0.90
97 Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus. J Virol 2013 0.90
98 An N-terminal amphipathic helix in dengue virus nonstructural protein 4A mediates oligomerization and is essential for replication. J Virol 2013 0.90
99 Innovative low cost technologies for biomedical research and diagnosis in developing countries. BMJ 2004 0.88
100 On-chip magnetic separation of superparamagnetic beads for integrated molecular analysis. J Appl Phys 2010 0.84
101 Composition of the sequence downstream of the dengue virus 5' cyclization sequence (dCS) affects viral RNA replication. Virology 2011 0.84
102 Molecular genomic approaches to infectious diseases in resource-limited settings. PLoS Med 2009 0.84
103 Regarding "Dengue--how best to classify it". Clin Infect Dis 2012 0.83
104 Molecular typing of dengue virus type 2 in Brazil. Rev Inst Med Trop Sao Paulo 2003 0.83
105 Performance of an influenza rapid test in children in a primary healthcare setting in Nicaragua. PLoS One 2009 0.82
106 Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo. Antimicrob Agents Chemother 2012 0.82
107 Complete nucleotide sequence analysis of a Brazilian dengue virus type 2 strain. Mem Inst Oswaldo Cruz 2002 0.80
108 Genetic analysis of Dengue 3 virus subtype III 5' and 3' non-coding regions. Virus Res 2008 0.80
109 Original antigenic sin in dengue revisited. Proc Natl Acad Sci U S A 2013 0.79
110 Immunoglobulin M enzyme-linked immunosorbent assay using recombinant polypeptides for diagnosis of dengue. Clin Diagn Lab Immunol 2005 0.78
111 NIAID workshop on Flavivirus immunity. Viral Immunol 2010 0.76
112 Burden of Influenza and Influenza-associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua. Pediatr Infect Dis J 2016 0.76
113 Open-access science: a necessity for global public health. PLoS Pathog 2005 0.75
114 The Timeline of Influenza Virus Shedding in Children and Adults in a Household Transmission Study of Influenza in Managua, Nicaragua. Pediatr Infect Dis J 2016 0.75
115 Recombinant polypeptide antigen-based immunoglobulin G enzyme-linked immunosorbent assay for serodiagnosis of dengue. Clin Vaccine Immunol 2007 0.75
116 Straight talk from... Eva Harris. Nat Med 2007 0.75